Publications (262) JUAN FRANCISCO ARENILLAS LARA publications

filter_list

2025

  1. Association of Reperfusion and Procedural Characteristics with Endovascular Thrombectomy Outcomes in Large Core Stroke: Sub-Analysis from the SELECT2 Trial

    Annals of Neurology, Vol. 97, Núm. 1, pp. 175-184

  2. Clinical and Economic Impact of a First Major Bleeding Event in Non-Anticoagulated Patients in Spain: A 3-Year Retrospective Observational Cohort Study

    Journal of Clinical Medicine, Vol. 14, Núm. 4

  3. Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: A secondary analysis of the SELECT2 randomized trial

    Journal of NeuroInterventional Surgery, Vol. 17, Núm. 2, pp. 120-127

  4. Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke

    European Journal of Neurology, Vol. 32, Núm. 1

  5. Selection of patients for percutaneous closure in nonlacunar cryptogenic stroke associated with patent foramen ovale. Data from the NORDICTUS cooperative registry

    Neurologia, Vol. 40, Núm. 2, pp. 139-149

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. A systematic review of the socioeconomic impact of mechanical thrombectomy for acute ischemic stroke

    Journal of Stroke and Cerebrovascular Diseases, Vol. 33, Núm. 11

  3. Anticoagulation Use and Endovascular Thrombectomy in Patients with Large Core Stroke: A Secondary Analysis of the SELECT2 Trial

    Annals of Neurology, Vol. 96, Núm. 5, pp. 887-894

  4. Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study

    Journal of Clinical Medicine, Vol. 13, Núm. 6

  5. Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study

    Journal of Clinical Medicine, Vol. 13, Núm. 14

  6. Critical Care Decisions After Large Core Cerebral Infarctions: A Secondary Analysis From the SELECT2 Trial

    Annals of Neurology

  7. Effect of a diabetes-specific formula in non-diabetic inpatients with stroke: a randomized controlled trial

    Nutrition and Diabetes, Vol. 14, Núm. 1

  8. Embolic Events in Infective Endocarditis: A Comprehensive Review

    Reviews in Cardiovascular Medicine, Vol. 25, Núm. 3

  9. Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients with Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial

    JAMA Neurology, Vol. 81, Núm. 4, pp. 327-335

  10. Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles

    JAMA, Vol. 331, Núm. 9, pp. 750-763

  11. Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial

    The Lancet, Vol. 403, Núm. 10428, pp. 731-740

  12. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

  13. Influence of dehydration on collateral circulation and clinical outcome after endovascular therapy in patients with acute ischemic stroke

    Neurologia

  14. Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial

    The Lancet Neurology, Vol. 23, Núm. 12, pp. 1205-1213

  15. NEIVATECH pilot study: immersive virtual reality training in older amblyopic children with non-compliance or non-response to patching

    Scientific Reports, Vol. 14, Núm. 1